This Sjögren's Drug Helped With Dryness
Dazodalibep's phase 3 results: dryness improved nearly twice as much as placebo. What the numbers show, what's missing, and 3 steps to take now.
Written by Dr. Kara Wada

Dazodalibep's phase 3 results: dryness improved nearly twice as much as placebo. What the numbers show, what's missing, and 3 steps to take now.

The ianalumab trials beat placebo by about one point, and dryness, fatigue, and pain didn't move. Who the trials left out, and why hope isn't optimism.

Allergy pill helping? That doesn't tell you if it's fall allergies or MCAS. Nurse Jen shares a two-question test and the red flags to name to your clinician.

Fatigue affects about 70% of people with Sjögren's disease. Here's why December costs more, why it hits in January, and what helps.


© 2025 Dr Kara Wada. All Rights Reserved.